172 related articles for article (PubMed ID: 16159528)
1. Diagnostic significance of membrane attack complex and vitronectin in childhood dermatomyositis.
Sakuta R; Murakami N; Jin Y; Nagai T; Nonaka I; Nishino I
J Child Neurol; 2005 Jul; 20(7):597-602. PubMed ID: 16159528
[TBL] [Abstract][Full Text] [Related]
2. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
[TBL] [Abstract][Full Text] [Related]
3. Membrane attack complex deposits in cutaneous lesions of dermatomyositis.
Mascaró JM; Hausmann G; Herrero C; Grau JM; Cid MC; Palou J; Mascaró JM
Arch Dermatol; 1995 Dec; 131(12):1386-92. PubMed ID: 7492126
[TBL] [Abstract][Full Text] [Related]
4. Microvascular alterations and the role of complement in dermatomyositis.
Lahoria R; Selcen D; Engel AG
Brain; 2016 Jul; 139(Pt 7):1891-903. PubMed ID: 27190020
[TBL] [Abstract][Full Text] [Related]
5. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis.
Kissel JT; Halterman RK; Rammohan KW; Mendell JR
Arch Neurol; 1991 Jan; 48(1):26-30. PubMed ID: 1986724
[TBL] [Abstract][Full Text] [Related]
6. C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases.
Braczynski AK; Harter PN; Zeiner PS; Drott U; Tews DS; Preusse C; Penski C; Dunst M; Weis J; Stenzel W; Mittelbronn M
Neuromuscul Disord; 2016; 26(4-5):283-91. PubMed ID: 27020463
[TBL] [Abstract][Full Text] [Related]
7. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
[TBL] [Abstract][Full Text] [Related]
8. Microvascular changes in early and advanced dermatomyositis: a quantitative study.
Emslie-Smith AM; Engel AG
Ann Neurol; 1990 Apr; 27(4):343-56. PubMed ID: 2353792
[TBL] [Abstract][Full Text] [Related]
9. Microvascular deposition of complement membrane attack complex in dermatomyositis.
Kissel JT; Mendell JR; Rammohan KW
N Engl J Med; 1986 Feb; 314(6):329-34. PubMed ID: 3945256
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical differentiation of inflammatory myopathies.
Panicker JB; Chacko G; Patil AK; Alexander M; Muliyil J
Neurol India; 2011; 59(4):513-20. PubMed ID: 21891925
[TBL] [Abstract][Full Text] [Related]
11. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lesions of dermatomyositis with supervening fibrosis.
Magro CM; Dyrsen M; Kerns MJ
J Cutan Pathol; 2008 Jan; 35(1):31-9. PubMed ID: 18095992
[TBL] [Abstract][Full Text] [Related]
13. Monocyte/macrophage differentiation in dermatomyositis and polymyositis.
Rostasy KM; Piepkorn M; Goebel HH; Menck S; Hanefeld F; Schulz-Schaeffer WJ
Muscle Nerve; 2004 Aug; 30(2):225-30. PubMed ID: 15266639
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.
Gonçalves FG; Chimelli L; Sallum AM; Marie SK; Kiss MH; Ferriani VP
J Rheumatol; 2002 Jun; 29(6):1301-7. PubMed ID: 12064850
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
Grundtman C; Tham E; Ulfgren AK; Lundberg IE
Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
[TBL] [Abstract][Full Text] [Related]
16. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle.
De Visser M; Emslie-Smith AM; Engel AG
J Neurol Sci; 1989 Dec; 94(1-3):181-92. PubMed ID: 2614466
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
Arthritis Rheum; 2004 May; 50(5):1586-94. PubMed ID: 15146429
[TBL] [Abstract][Full Text] [Related]
18. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
Takahashi T; Inaba S; Okada T
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
[TBL] [Abstract][Full Text] [Related]
19. Expression of the membrane attack complex of complement and its inhibitors during human liver allograft transplantation.
Conti F; Grude P; Calmus Y; Scoazec JY
J Hepatol; 1997 Nov; 27(5):881-9. PubMed ID: 9382976
[TBL] [Abstract][Full Text] [Related]
20. Vascular pathology in dermatomyositis and anatomic relations to myopathology.
Pestronk A; Schmidt RE; Choksi R
Muscle Nerve; 2010 Jul; 42(1):53-61. PubMed ID: 20544925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
